Kiyoshi Yoshimura

5PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 27, 2026
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.

|Mar 18, 2025
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8+ T cells as a predictor of clinical benefit.

Toshiaki Tsurui, Masahiro Hosonuma, Aya Sasaki

|Jan 23, 2024
Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.

Masahiro Hosonuma, Yuya Hirasawa, Atsuo Kuramasu

|Feb 27, 2023
Association of microbiota with cancer treatment.

Kiyoshi Yoshimura

|Jun 11, 2021
A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy.

Yuya Hirasawa, Kiyoshi Yoshimura, Hiroto Matsui

Pageof 1

Frequent Collaborators

2 joint publications

Kazuyuki Hamada

2 joint publications

Ryotaro Ohkuma

2 joint publications

Satoshi Wada

1 joint publications

Atsushi Horiike